153 related articles for article (PubMed ID: 31591043)
1. FDG PET/CT vs. NaF PET/CT in relapsing polychondritis.
Liu Y; Xia Y; Chen Y; Cai L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):35-36. PubMed ID: 31591043
[No Abstract] [Full Text] [Related]
2. Is
Zeng Y; Li M; Chen S; Lin L; Li S; He J; Wang J
Arthritis Res Ther; 2019 Dec; 21(1):282. PubMed ID: 31831053
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT is an ideal imaging modality for the early diagnosis of relapsing polychondritis: A case report.
Wang J; Liu X; Pu C; Chen Y
Medicine (Baltimore); 2017 Jul; 96(30):e7503. PubMed ID: 28746194
[TBL] [Abstract][Full Text] [Related]
4. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis.
Sharma A; Kumar R; Mb A; Naidu GSRSNK; Sharma V; Sood A; Dhir V; Verma R; Singh H; Bhattacharya A; Jain S; Mittal BR
Rheumatology (Oxford); 2020 Jan; 59(1):99-106. PubMed ID: 31236569
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT imaging of relapsing polychondritis: A case report.
Zhou H; Su M; Li L
Medicine (Baltimore); 2016 Aug; 95(33):e4496. PubMed ID: 27537572
[TBL] [Abstract][Full Text] [Related]
7. Relapsing polychondritis on PET/CT.
Deng H; Chen P; Wang L; Li X; Yi J
Clin Nucl Med; 2012 Jul; 37(7):712-5. PubMed ID: 22876362
[TBL] [Abstract][Full Text] [Related]
8. Imaging features and clinical value of
Yi JW; Huang JF; Hou P; Lin ZK; Lin JS; Lin SY; Wang M; Li SY; Wang XL
Arthritis Res Ther; 2023 Oct; 25(1):198. PubMed ID: 37838717
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Monitoring of Osteoporosis with Total-Body
Zhang V; Koa B; Borja AJ; Padmanhabhan S; Bhattaru A; Raynor WY; Rojulpote C; Seraj SM; Werner TJ; Rajapakse C; Alavi A; Revheim ME
PET Clin; 2020 Oct; 15(4):487-496. PubMed ID: 32768370
[TBL] [Abstract][Full Text] [Related]
10. Incidental Case of Relapsing Polychondritis Detected by 18F-FDG PET/CT.
Kaida H; Ishii K; Hanada S; Tohda Y; Murakami T
Clin Nucl Med; 2018 Jan; 43(1):25-27. PubMed ID: 29189373
[TBL] [Abstract][Full Text] [Related]
11. FDG PET-CT as a powerful tool for diagnosing and monitoring treatment outcomes of relapsing polychondritis.
Baudart P; Aouba A; Beaufrère M; Aide N
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):669-670. PubMed ID: 29234846
[No Abstract] [Full Text] [Related]
12. Fluorodeoxyglucose PET in relapsing polychondritis.
De Geeter F; Vandecasteele SJ
N Engl J Med; 2008 Jan; 358(5):536-7. PubMed ID: 18234765
[No Abstract] [Full Text] [Related]
13. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnostic imaging in relapsing polychondritis with atypical manifestations.
Honne K; Nagashima T; Onishi S; Nagatani K; Iwamoto M; Minota S
J Clin Rheumatol; 2013 Mar; 19(2):104-5. PubMed ID: 23425669
[No Abstract] [Full Text] [Related]
14. F-18 FDG PET/CT in relapsing polychondritis.
Sato M; Hiyama T; Abe T; Ito Y; Yamaguchi S; Uchiumi K; Hashimoto I; Kaburagi T
Ann Nucl Med; 2010 Nov; 24(9):687-90. PubMed ID: 20737256
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
17. Relapsing Polychondritis: The Oto-Rhino-Tracheobronchial Triad on 18 F-FDG PET/CT.
Kwok SH; Choi F
Clin Nucl Med; 2023 Aug; 48(8):699-701. PubMed ID: 37276545
[TBL] [Abstract][Full Text] [Related]
18. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
Xu F; Liu F; Pastakia B
Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
[TBL] [Abstract][Full Text] [Related]
19. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
Kim Y; Lee HY; Yoon HJ; Kim BS
J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011
[TBL] [Abstract][Full Text] [Related]
20. Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches.
Zadeh MZ; Raynor WY; Seraj SM; Ayubcha C; Kothekar E; Werner T; Alavi A
PET Clin; 2019 Jul; 14(3):341-352. PubMed ID: 31084774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
